<DOC>
	<DOCNO>NCT02767596</DOCNO>
	<brief_summary>The study aim examine effectiveness short act GLP-1 analog , Lixisenatide achieve glycemic control type 2 diabetes patient , patient failure long acting GLP-1 analog . Patients fail achieve significant improvement diabetes control basal insulin Liraglutide switch basal insulin lixisenatide treatment 12 week . The primary outcome change HBA1C weight .</brief_summary>
	<brief_title>Evaluation Lixisenatide Efficacy Diabetes Mellitus Type 2 With Failure Other GLP-1 Analog</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type Diabetes Mellitus combination basal insulin therapy GLP1 analog , secondary failure nonfasting glycemic control Pregnant lactate woman Renal failure ( eGFR &lt; 30 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>treatment</keyword>
	<keyword>GLP-1</keyword>
</DOC>